MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration.

MLA

Zhang, Hai-Jun, et al. “MAPK /ERK Signaling Pathway: A Potential Target for the Treatment of Intervertebral Disc Degeneration.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 143, Nov. 2021, p. 112170. EBSCOhost, https://doi.org/10.1016/j.biopha.2021.112170.

APA

Zhang, H.-J., Liao, H.-Y., Bai, D.-Y., Wang, Z.-Q., & Xie, X.-W. (2021). MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 143, 112170. https://doi.org/10.1016/j.biopha.2021.112170

Chicago

Zhang, Hai-Jun, Hai-Yang Liao, Deng-Yan Bai, Zhi-Qiang Wang, and Xing-Wen Xie. 2021. “MAPK /ERK Signaling Pathway: A Potential Target for the Treatment of Intervertebral Disc Degeneration.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 143 (November): 112170. doi:10.1016/j.biopha.2021.112170.